Synergy Health (SYR)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | 15.8 |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 1.98 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Mar | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014E | 2015E | CAGR / Avg | |
| Revenue | £m | |||||||||
| Operating Profit | £m | |||||||||
| Net Profit | £m | |||||||||
| EPS Reported | p | |||||||||
| EPS Normalised | p | |||||||||
| EPS Growth | % | |||||||||
| PE Ratio | x | |||||||||
| PEG | x | |||||||||
| Profitability | ||||||||||
| Operating Margin | % | |||||||||
| ROA | % | |||||||||
| ROCE | % | |||||||||
| ROE | % | |||||||||
| Cashflow | ||||||||||
| Op. Cashflow ps | p | |||||||||
| Capex ps | p | |||||||||
| Free Cashflow ps | p | |||||||||
| Last ex-div: 7th Aug, paid: 5th Sep more... Dividends | ||||||||||
| Dividend ps | p | |||||||||
| Dividend Growth | % | |||||||||
| Dividend Yield | % | |||||||||
| Dividend Cover | x | |||||||||
| Balance Sheet | ||||||||||
| Cash etc | £m | |||||||||
| Working Capital | £m | |||||||||
| Net Fixed Assets | £m | |||||||||
| Net Debt | £m | |||||||||
| Book Value | £m | |||||||||
| Average Shares | m | |||||||||
| Book Value ps | p | +7.3% | ||||||||
FINANCIAL BRIEF: For the fiscal year ended 31 March 2013, Synergy Healthcare plc revenues increased 16% to L361.2M. Net income increased 27% to L31.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest Income increase from L1.7M to L4.9M (income), Non-Recurring Costs decrease of 7% to L2.4M (expense). Dividend per share increased from L0.18 to L0.21. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Mar '13) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 1 | 0 | 3 | 1 | 3 |
Synergy Health plc delivers a range of specialist outsourced services to healthcare providers and other customers concerned with health management. The Company operates in four operating segments: the UK and Ireland, Europe and Middle East, Asia and Africa and Americas. The segments derive their revenues from a range of products and services, being the provision of Healthcare Services, Applied Sterilisation Services and Hospital Sterilisation Services. Its healthcare solutions covers a range of services which include infection control. It provides a range of sterilisation technologies, including gamma irradiation; electron and ion beam. Its Hospital Sterilisation Services include instrument sterilisation service. In March 2012, it acquired Leoni Studer Hard AG from Leoni Group. On March 21, 2012, it acquired MSI Surgical Solutions LLC. In July 2012, it acquired SRI/Surgical Express, Inc.
Directors: Richard Steeves (CEO) 50, Gavin Hill (Fin. Dir.) , Adrian Coward (Corp. Exec.) , Niclas Olsson (Corp. Exec.) , Marcello Smit (Corp. Exec.) 50, Glenn Thibault (Corp. Exec.) , Paul Santing (Other) , Tim Mason (Secy.) 47,
No. of Employees: 4,399 No. of Shareholders: n/a
| Last Annual | March 31st, 2013 |
| Last Interim | March 31st, 2013 |
| Shares in Issue | 58,527,342 |
| Free Float | 55.6m (95.1%) |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | FTSE 350 Act , FTSE Lower Yield , FTSE 250 Mid , FT350 Hlth Eq&sr , |
| Exchange |
London Stock Exchange (SETS) |
| Eligible for | an ISA? a SIPP? |
| Address | Ground Floor Stella,Windmill Hill Business Park, Whitehill Way, SWINDON, SN5 6NX, United Kingdom |
| Web | http://www.synergyhealthplc.com/ |
| Phone | +44 1793 891880 |
| Contact | Richard Steeves (Group Chief Executive, Executive Director) |
| Registrar | Computershare Investor Services PLC (Bristol) |
| Auditors | KPMG Audit PLC |
| 5th Jun | Final Results |
| 31st May | Total Voting Rights |
| 18th Apr | Trading Statement |
| 16th Apr | Holding(s) in Company |
| 2nd Apr | Total Voting Rights |
| 1st Mar | Total Voting Rights |
Recent ↓
